AG
TMDX icon

Aperio Group’s Transmedics TMDX Stock Holding History

Aperio Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$199K Buy
+10,025
New +$148K ﹤0.01% 2309

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Aperio Group's TMDX Position: Q4 2020 in Review

Aperio Group opened a new position in Transmedics (TMDX) in Q4 2020: 10,025 shares worth $199K. The stake represents ﹤0.01% of the portfolio and ranks #2309 among its holdings.

69 funds tracked by Wall St. Rank hold TMDX as of Q4 2020.

  • Aperio Group held 10,025 shares of Transmedics worth $199K as of Q4 2020.
  • Transmedics was a new Aperio Group position in Q4 2020.
  • Transmedics made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2309 holding.
  • 69 funds tracked by Wall St. Rank held Transmedics as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.